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Introduction: The number of total hip and total knee replacement procedures performed worldwide has tended
to surge in recent years, due to the combination of such factors as the increased life expectancy, improved quality
of life, advances in medical technology as well as pre-operative and post-operative patient management.
Numerous studies confirm that patients undergoing major orthopaedics procedures involving lower extremities, for
instance total hip and total knee replacement, constitute the highest risk group for the development of post-operative
venous thromboembolism (VTE), primarily manifested as deep vein thrombosis (DVT).
Purpose: The purpose of the research was to assess the dynamics of D-dimer level fluctuation during the post-operative
period in patients after the cemented or cementless total hip replacement (THR) or total knee replacement (TKR), in order
to prove or reject the thesis that the cemented and cementless THR or TKR affects the post-operative D-dimer levels.
Material and methods: The study group consisted of 47 patients aged 29–82 years. Of them, 23 had the cementless
THR, 12 subjects had the cemented THR and another 12 patients had the TKR. All of the patients performed to measure
the concentration of D-dimers in the peri-operative period at predetermined time points. For the peri-operative period
was adopted from time 1 day before surgery to 10-day hospitalization. The subarachnoid block (SAB) was performed in
all patients.
Results: The distribution of D-dimer values throughout the entire post-operative period (up to 10th post-operative day)
followed the sinusoid pattern with two peaks in all patients. It was not specific in any group.
Conclusions:
1. The D-dimer level almost doubles during the post-operative period in patients after THR or TKR.
2. Higher level of D-dimers in post-operative period in the research group of patients does not relate to higher risk of
thromboembolic disease.
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D-dimers are fibrin degradation products formed as a
result of fibrin clot dissolution by plasmin. They partici-
pate in the entire homeostasis mechanism including co-
agulation and fibrinolysis processes. Under physiological
conditions, both processes should take place simultan-
eously, maintaining some balance.* Correspondence: biuro@ortokos.pl
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article, unless otherwise stated.As long as the processes are normal and balanced, the
body is protected against bleeding as well as against
thrombus formation. When bleeding occurs, the appro-
priate mechanisms are activated leading to thrombus
formation out of fibrin, which stops the bleeding. After
the thrombus is dissolved by plasmin, the fibrin degrad-
ation products such as D-dimers are released. Their ele-
vated plasma concentration indicates that the coagulation
and fibrinolysis mechanisms were triggered. D-dimer level
measurement is not included in the routine pre-operativetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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suspected venous thromboembolism (VTE), manifested as
deep vein thrombosis (DVT) or pulmonary embolism (PE)
[1]. But it may also be used as a part of diagnosis or moni-
toring of patients with disseminated intravascular co-
agulation (DIC) [2]. The term venous thromboembolism
encompasses two elements: deep vein thrombosis and
pulmonary embolism. It implies that while deep vein
thrombosis is the primary manifestation of the disease,
pulmonary embolism may follow as the sequelae.
Numerous studies confirmed that patients undergoing
major orthopaedic procedures involving lower extrem-
ities, for instance total hip and total knee replacement,
constitute the highest risk group for the development
of post-operative venous thromboembolism, primarily
manifested as the deep vein thrombosis [3-5]. The num-
ber of total hip and total knee replacement procedures
performed worldwide has tended to surge in recent
years, due to the combination of such factors as the
increased life expectancy, improved quality of life, ad-
vances in medical technology as well as pre-operative and
post-operative patient management. Although D-dimers
are specific as fibrin degradation products, fibrin itself is
not specific for venous thromboembolism only. The
increased fibrin production, which is manifested by the
elevated D-dimer concentration, can also be observed in
other clinical conditions, such as cancer, infection, inflam-
mation, surgery, injuries, haemorrhages, extensive burns,
cerebral stroke, aortic aneurysm rupture, ischemic heart
disease, myocardial infarction (MI), rheumatoid arthritis
(RA), pregnancy and postpartum period as well as in eld-
erly patients, patients with haematomas, extensive bruises
and many others [3,6,7].
The prospective studies show that the negative result
of D-dimer assay, that is the value below the cutoff point
(usually 500 ng/ml), makes it possible to exclude the dis-
ease and to refrain safely from anticoagulation therapy
in patients with moderate or low clinical potential for
the venous thromboembolism, assessed using Wells pre-
diction rules [8-11]. On the other hand, the elevated
D-dimer level does not have a confirmatory value for
venous thromboembolism due to low specificity of the
assay. Therefore, the assay should not be used in order to
diagnose DVT or PE, as not every patient with the
elevated D-dimer level has an acute episode of VTE.
Purpose
The purpose of the research was to assess the dynamics
of D-dimer level fluctuation during the post-operative
period in patients after the cemented or cementless total
hip replacement (THR) or total knee replacement (TKR),
in order to prove or reject the thesis that the cemented
and cementless total hip or total knee replacement affects
the post-operative D-dimer levels.Material and methods
Fifty patients (35 women and 15 men) aged 29–82 years
were enrolled in the study. All subjects gave their
informed consent to participate in the study (informed
consent form, patient information form). Twenty-three
of them had the cementless THR, 15 subjects had the
cemented THR and another 12 patients had the TKR.
All procedures were performed in the Department of
Orthopedics and Traumatology, Health Maintenance
Organization in Turek. Three patients after the cemented
THR were eventually excluded from the analysis, due to
the impossibility to perform the D-dimer measurements
at all required time points as a result of technical difficul-
ties. Therefore, the final study sample consisted of 47
subjects (32 women and 15 men). The study protocol
was approved by the Institutional Review Board at the
Karol Marcinkowski Medical University of Poznań, by
the virtue of Resolution no. 739/11.
Inclusion criteria:
– Degenerative hip or knee lesions, making the patient
eligible for surgery
– Category I–III at the assessment of physical status
classified according to the system developed by the
American Society of Anaesthesiology (ASA)
– Health insurance holders (National Health Fund)
Exclusion criteria:
– Current diagnosis or a history of VTE
– Joint injury (involving the joint scheduled for




– Use of oral anticoagulants
– ASA category > III
– Age <18 years
– Legal incapacity
Detailed medical history was obtained, and physical
examination was performed in each patient prior to the
scheduled surgery. The anamnesis involved the history
of chronic diseases and surgery, all chronic comorbidi-
ties and their treatment as well as currently used VTE
prevention. The respiratory and cardiovascular function
was assessed during the physical examination. At the
same time, the lower extremities were evaluated for vari-
cose veins, and the type of total hip/knee implant was
determined. Prior to the surgery, the following assays
were routinely performed. None of the enrolled patients
was diagnosed with venous thromboembolism based on
clinical assessment and venous ultrasound scan. The
perioperative period was referred to as the period from
Table 1 Characteristics of the population of patients in
terms of gender, age and including factors BMI and
international ASA scale
Characteristics of the population of patients
All patients in study (47)
Sex (%) Female Male
68.085 31.914
Subjects 32 15
ASA I ASA II ASA III
12.766 31.915 55.319
6 15 26
Min Max Mean value
Age in years 29 82 66.1
BMI (kg/m2) 21.273 41.207 29.557
Cementless total hip replacement (23)
Sex (%) Female Male
60.87 39.13
Subjects 14 9
ASA (%) ASA I ASA II ASA III
26.087 30.435 43.478
Subjects 6 7 10
Min Max Mean value
Age in years 29 75 58.696
BMI (kg/m2) 21.273 38.587 28.953




ASA (%) ASA I ASA II ASA III
0 50 50
Subjects 0 6 6
Min Max Mean value
Age in years 56 79 66.917
BMI (kg/m2) 27.349 35.467 30.967
Cemented total hip replacement (12)
Sex (%) Female Male
83.333 16.667
Subjects 10 2
ASA I ASA II ASA III
0 16.667 83.333
0 2 10
Min Max Mean value
Age in years 58 82 72.667
BMI (kg/m2) 25.368 41.207 29.307
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operatively, although this definition is broader than the
ones commonly accepted in anaesthesiology.
In the whole peri-operative period, the D-dimer level
in blood plasma was assessed by immunoenzymatic au-
tomated quantity test VIDAS D-Dimer Exclusion carried
out in the immunoanalyzer VIDAS and based on mark-
ing fibrin degradation products (FbDP) in human blood
plasma (with sodium citrate) with the use of enzyme-
linked fluorescent assay (ELFA) technique. According
to the data provided by the manufacturer (Bio-Merieux,
Lyon, France), measuring range VIDAS D-Dimer Exclusion
area from 45 ng/ml to 10,000 ng/ml cutoff point of
500 ng/ml, the sensitivity of about 100%, a negative
predictive value (NPV) of about 100% and a specificity
of about 40% [12].
The following time points have been assumed for the
assays:
I. On the day preceding surgery—the pre-operative
assay # “0”
II. 12 h post-operatively—assay # “1”
III. On the 1st post-operative day—assay # “2”
IV. On the 2nd post-operative day—assay # “3”
V. On each consecutive day, until the 10th post-
operative day—final assay # “11”
All enrolled patients received VTE prevention, which
involved administration of low molecular weight
heparin at doses recommended by the Polish Society
of Orthopaedics and Traumatology [13]. The preventive
heparin use was prolonged up to 6 weeks post-operatively.
The premedication administered approx. 40–50 min prior
to the scheduled surgery involved Midazolam p.o. or i.m.
at the dose of 0.07–0.1 mg/kg. Moreover, each patient
received 1.0 g of Metamizole sodium dissolved in 500 ml
of saline as an intravenous (i.v.) infusion. The subarach-
noid block (SAB) was done in all patients using a single
puncture technique with the patient sitting.
All patients were administered 1,000 mg of Tranexamic
acid i.v. and infusion fluids at the dose of 20 ml/kg
(i.e. approx. 1,500–2,000 ml) during the surgery. The
administered infusion fluids comprised specifically of:
10% hydroxyethyl starch (HES) 200/0.5, 500 ml; the
multielectrolyte solution, 500 ml; 0.9% sodium chloride
(saline), 500 ml plus potentially another 500 ml bag.
Moreover, if necessary, packed red blood cells, hydrocorti-
sone (for cemented implants), sedatives (Midazolam) or
other drugs were administered i.v. based on the physician’s
judgement. Atropine sulphate was also administered in
cases of heart rate drop by 25% as compared to baseline
value. Similarly, ephedrine hydrochloride was adminis-
tered in cases of mean blood pressure drop by 25% as
compared to the baseline value determined during the first
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taken to prevent the blood pressure drop by 35% as com-
pared to the baseline value.
Statistical analysis
As most of the studied variables did not follow normal
distribution, the following non-parametric tests were
used for the analysis:
 In order to verify the differences between the D-dimer
levels at various time points within the same patient
group, the Wilcoxon signed rank test was used.
 In order to verify the differences in percentage changes
in D-dimer levels between the patient groups, the
Mann-Whitney U-test was used.
 In order to assess the correlation between the baseline
D-dimer level and the patient age, the Spearman’s rank
correlation coefficient was calculated.
The p level of < .05 was assumed for all comparisons.
Results
Characteristics for all sampled groups of patients: cement-
less total hip replacement (cementless THR), TKR, cemen-
ted total hip replacement (cemented THR) in terms of
gender, age, BMI, past history expressed and evaluated by
the international ASA scale are presented in Table 1.
The pre-operative D-dimer levels are presented in
Table 2. The baseline D-dimer level exceeded the refer-
ence value of 500 ng/mL in 37 out of 47 subjects. In most
cases, this excess was attributed to patient age and their
comorbidities. The D-dimer levels in all subjects, measured
12 h post-operatively are presented in Table 2.
The elevated D-dimer level at 12 h post-operatively
was shown in 46 out of 47 subjects. It was the highestTable 2 Growth differentiation of D-dimer levels in each grou
The D-dimer levels (ng/m) Cementless total hip replaceme
mean age 58.7 years
Min Max Mean valu
1. The pre-operative D-dimer levels (ng/mL) 146.43 2,676.33 1,077.223
2. D-dimer levels measured 12 h
post-operatively (ng/mL)
1,332.1 10,000.00 6,995.55
3. D-dimer levels measured post-operatively
on day 1st (ng/mL)
887.97 10,000.00 3,152.338
4. The lowest D-dimer levels measured
post-operatively on days 2 and 3 (ng/mL)
654.16 4,523.55 1,546.635
5. D-dimer levels measured post-operatively
on days 3 and 4 (ng/mL)
1,312.47 4,523.55 2,536.357
6. The highest D-dimer levels measured
post-operatively on days 4–10 (ng/mL)
1,723.36 7,862.14 3,879.205
7. D-dimer level measured post-operatively
on day 10 (ng/mL)
898.39 9,601.73 3,268.066increase in D-dimer level observed throughout the entire
follow-up period, which reached the peak of 10,000 ng/mL
in almost half of the study group. Moreover, a statis-
tically significant difference was found between the
mean D-dimer levels at12 h post-operatively and the
baseline values across all study groups (cementless THR,
p <0.001; total knee replacement, p =0.002; cemented
THR, p =0.006). The D-dimer levels in all subjects,
measured on the1st post-operative day are presented in
Table 2.
The D-dimer level decreased in all subjects on the 1st
post-operative day compared to the level measured at
12 h post-operatively. However, the obtained values still
exceeded the baseline levels. A statistically significant
difference between the mean D-dimer level on the 1st
post-operative day, compared to the measurement 12 h
post-operatively was shown in all groups (cementless
THR, p <0.001; TKR, p =0.003; cemented THR, p =0.008).
Similarly, a statistically significant difference between the
D-dimer level on the 1st post-operative day and its baseline
values was found across all groups (cementless THR,
p <0.001; TKR, p =0.002; cemented THR, p =0.034).
The lowest D-dimer levels on the 2nd–3rd post-operative
day are presented in Table 2.
The lowest D-dimer levels throughout the entire post-
operative period were observed in all subjects on the
2nd–3rd post-operative day. A statistically significant dif-
ference between the mean D-dimer level on the 2nd–3rd
post-operative day, compared to its value on the 1st post-
operative day was shown in all patient groups (cementless
THR, p <0.001; TKR, p =0.002; cemented THR, p =0.005).
Furthermore, a statistically significant difference between
the D-dimer level on the 2nd–3rd post-operative day and
mean baseline value was shown in two patient groups
(cementless THR, p <0.019; TKR, p =0.004).p of patients
nt Total knee replacement
mean age 66.9 years
Cemented total hip replacement
mean age 72.7 years
e Min Max Mean value Min Max Mean value
251.66 2,960.38 1,025.141 337.28 5,315.56 2,075.353
3,626.18 10,000.00 8,571.276 1,681.13 10,000.00 6,569.658
1,497.00 10,000.00 6,232.967 917.85 7,882.89 3,478.125
912.05 4,404.59 2,494.083 800.27 3,235.43 1,582.428
1,441.38 4,404.59 3,331.502 1,050.91 3,921.62 2,174.206
2,360.15 8,110.22 5,032.932 2,422.00 10,000.00 4,422.438
1,752.18 5,839.16 3,721.137 2,005.96 8,019.52 4,029.627
Figure 1 Mean pre-operative and final (10th post-operative day) D-dimer level (ng/ml) all study groups.
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therefore, it was not considered statistically significant.
The D-dimer levels on the 3rd–4th post-operative day
are presented in Table 2.
The subsequent rise of D-dimer level from the 3rd–
4th post-operative day onwards was observed in all sub-
jects. A statistically significant difference between the
mean D-dimer level on the 3rd–4th post-operative day,
compared to its value on the 2nd–3rd post-operative
day was shown in all patient groups (cementless THR,
p <0.001; TKR, p =0.005; cemented THR, p =0.002).
The highest D-dimer levels measured post-operatively
on days 4th–10th are presented in Table 2.
A statistically significant difference between the mean
D-dimer levels on the 4–10th post-operative day, com-
pared to the mean baseline values was observed in
all groups (cementless THR, p <0.001; TKR, p =0.002;
cemented THR, p =0.002). The D-dimer levels on the
10th post-operative day are presented in Table 2.
Figure 1 shows the comparison of pre-operative and
final D-dimer levels. The D-dimer level on the 10thFigure 2 Cementless total hip replacement.post-operative day was still almost doubled compared to
the pre-operative value in most patients (Figure 1).
The D-dimer level measured post-operatively on day
10th was still almost twice as high as its pre-operative
value in most patients. That is why the physicians, who
continue the post-operative management of patients
after THR or total knee replacement procedures, may
expect the D-dimer concentrations to be significantly
elevated. A statistically significant difference between the
mean final D-dimer levels compared to the mean base-
line (pre-operative) values was observed in all groups
(cementless THR, p <0.001; TKR, p =0.002; cemented
THR, p =0.002). Figures 2, 3 and 4 show the mean D-dimer
levels for the three study groups, measured throughout
the entire follow up period (the vertical bars show the
mean value ± standard deviation) (Figures 2, 3 and 4).
Discussion
Developing effective measures of venous thromboembol-
ism detection is particularly important in patients under-
going total hip or total knee replacement, as they are at
Figure 3 Total knee replacement.
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our research, we attempted to determine the applicabil-
ity of D-dimer level measurements for the detection of
venous thromboembolism in these patients. We have de-
termined the ranges of D-dimer values measured during
the post-operative period in patients after total hip or
total knee replacement. These can be measured using
different laboratory methods. Only these methods, char-
acterized by the sensitivity and NPV close to 100%, consid-
ered along with the moderate or low clinical probability of
VTE according to Wells prediction rule, make it possible
to exclude the disease and justify the decision to refrain
from treatment with anti-coagulants [8].
As the standard reference values have not been deter-
mined yet, the obtained D-dimer level results should
be supplemented by the reference range for a specific
type of assay. Due to the fact the reference values
may be affected by multiple factors, such as patient age,Figure 4 Cemented total hip replacement.comorbidities, study population or assay type, the ob-
tained results expressed as numbers will be interpreted
differently and have variable applications in different
clinical settings. Moreover, D-dimer level can take a
false negative value in some circumstances, e.g. at the
presence of a small thrombus (in isolated distal DVT),
in case of temporal delay between the onset of symptoms
and the laboratory tests, or the use of anticoagulants
(heparin or oral anticoagulants) [3,6,14]. The negative
D-dimer values in patients with long-lasting symp-
toms of VTE should always be assessed with caution, as
the D-dimer level may drop within 1–2 weeks following
the symptom onset to only 1/4 of baseline value. However,
the risk of the patient does not decrease if the disease is
left untreated. Similarly, the D-dimer level decreases
in response to treatment with anticoagulants; it may
drop by 25% of baseline value within 24 h following
the first administration of unfractionated heparin [15].
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values throughout the entire post-operative period in our
study followed the sinusoid pattern in all patients, with
two peaks, and was not specific in any group.
Finally, it should be noted that the elevated D-dimer
level is not enough to diagnose VTE in patients after the
THR or TKR. Owing to the fact that there are no pub-
lished papers discussing the issues addressed in our
study, it is difficult to relate our findings to the results
and observations of other authors.
Conclusions
1. The D-dimer level almost doubles during the post-
operative period in patients after THR or TKR.
2. Higher level of d-dimers in post-operative period in
the research group of patients does not relate to
higher risk of thromboembolic disease.
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